NBIX - Neurocrine Biosciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2019
12/30/2018
12/30/2017
12/30/2016
Total Revenue
-
788,100
451,240
161,626
15,000
Cost of Revenue
-
7,400
4,889
1,254
-
Gross Profit
-
780,700
446,351
160,372
-
Operating Expenses
Research Development
-
354,300
160,524
121,827
94,291
Selling General and Administrative
-
354,100
248,932
169,906
68,081
Total Operating Expenses
-
708,400
409,456
291,733
162,372
Operating Income or Loss
-
72,300
36,895
-131,361
-147,372
Interest Expense
-
32,000
30,530
19,523
-
Total Other Income/Expenses Net
-
6,200
15,476
8,342
3,444
Income Before Tax
-
46,500
21,841
-142,542
-141,090
Income Tax Expense
-
9,500
730
-
-
Income from Continuing Operations
-
37,000
21,111
-142,542
-141,090
Net Income
-
37,000
21,111
-142,542
-141,090
Net Income available to common shareholders
-
37,000
21,111
-142,542
-141,090
Reported EPS
Basic
-
0.40
0.23
-1.62
-1.63
Diluted
-
0.39
0.22
-1.62
-1.63
Weighted average shares outstanding
Basic
-
91,627
90,235
88,089
86,713
Diluted
-
95,732
95,386
88,089
86,713
EBITDA
-
78,500
56,395
-120,619
-145,919